Hosted on MSN1d
GSK lowered to hold by Jefferies, valuation disconnect cited
Jefferies lowered GSK (NYSE:GSK) to hold, citing a valuation disconnect between fundamentals and price. Jefferies said it ...
TipRanks on MSN1d
GSK downgraded to Hold from Buy at Jefferies
Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...
MedPage Today1d
Which High-Risk Patients Should Get the RSV Vaccine?
The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
Daily2d
GSK RSV vaccine approved in Canada for adults aged 50-59 at increased risk
Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...
Doctors stress the importance of the RSV vaccine
With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.
Canada approves Moderna's RSV vaccine for those age 60 and older, company says
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
The Prince George Citizen4d
Health Canada approves Moderna's mRNA RSV vaccine, company says
There are two other vaccines already available in Canada to protect seniors against severe illness caused by RSV: Arexvy, ...
Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
FiercePharma6d
AbbVie's Skyrizi rockets to top of TV drug ad spenders' list with single largest monthly total this year
AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...